C

    Canopy Growth Corp (CGC)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $0.99
    -0.00 (-0.45%)

    Market Cap: $475.32M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    25%(10/40)
    Avg Surprise
    -160.63%
    Streak
    1 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.03
    Range$-0.03 - $-0.03
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$0.00+100.0%
    60d ago$0.00+100.0%
    30d ago$-0.03+0.0%
    7d ago$-0.03+0.0%
    Current$-0.03
    Revenue Consensus
    $82M
    Range$79M - $83M
    7 analysts
    Dec 31, 2026
    EPS Consensus$-0.01
    Range$-0.01 - $-0.01
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$0.00+100.0%
    60d ago$0.00+100.0%
    30d ago$-0.01+0.0%
    7d ago$-0.01+0.0%
    Current$-0.01
    Revenue Consensus
    $90M
    Range$84M - $93M
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Mar 27EST
    		-$0.00---
    Dec 26EST
    		-$-0.01---
    Sep 26EST
    		-$-0.03---
    Jun 26
    		$-0.02$-0.04+50.00%Beat+89.5%
    Mar 26
    		$-0.17$-0.06-183.33%Miss+88.1%
    Dec 25
    		$-0.14$-0.05-180.00%Miss+86.8%
    Sep 25
    		$-0.01N/A+90.91%Beat+99.2%
    Jun 25
    		$-0.19$-0.12-58.33%Miss+87.3%
    Mar 25
    		$-1.43$-0.25-472.00%Miss-38.8%
    Dec 24
    		$-1.06$-0.23-360.87%Miss+51.6%
    Sep 24
    		$-1.23$-0.32-284.38%Miss+42.5%
    Jun 24
    		$-1.50$-0.37-305.41%Miss-206.1%
    Mar 24
    		$-1.03$-0.45-128.89%Miss+19.5%
    Dec 23
    		$-2.19$-0.47-365.96%Miss+52.1%
    Sep 23
    		$-2.14$-1.16-84.48%Miss+35.0%
    Jun 23
    		$-0.49N/A+75.50%Beat+94.4%
    Mar 23
    		$-1.28$-0.20-540.00%Miss+12.3%
    Dec 22
    		$-4.57$-2.26-102.21%Miss-183.9%
    Sep 22
    		$-3.29$-2.60-26.54%Miss-2890.9%
    Jun 22
    		$-8.71$-2.81-209.96%Miss-172.0%
    Mar 22
    		$-1.46$-0.32-356.25%Miss+21.1%
    Dec 21
    		$-1.61$-3.17+49.21%Beat+87.5%
    Sep 21
    		$-0.11N/A+94.12%Beat-103.6%
    Jun 21
    		$12.10$-2.88+520.14%Beat+570.8%
    Mar 21
    		$-1.85$-0.26-611.54%Miss-19.4%
    Dec 20
    		$-12.86$-3.32-287.35%Miss-234.9%
    Sep 20
    		$3.04$-3.58+184.92%Beat+127.4%
    Jun 20
    		$-2.57$-4.94+47.98%Beat-756.7%
    Mar 20
    		$-1.55$-0.59-162.71%Miss+85.8%
    Dec 19
    		$-3.84$-4.66+17.60%Beat-6.1%
    Sep 19
    		$-11.08$-3.61-206.93%Miss+15.3%
    Jun 19
    		$-0.30$-0.51+41.18%Beat+25.0%
    Mar 19
    		$-10.91$-2.83-285.51%Miss-260.1%
    Dec 18
    		$-3.62$-2.14-69.16%Miss-135.1%
    Sep 18
    		$-13.08$-1.00-1208.00%Miss-990.0%
    Jun 18
    		$-0.40$-0.13-207.69%Miss+53.5%
    Mar 18
    		$-3.03$-0.75-304.00%Miss-2064.3%
    Dec 17
    		$-1.54$-0.70-120.00%Miss-258.1%
    Sep 17
    		$-1.20$-0.50-140.00%Miss-200.0%
    Jun 17
    		$-0.86$-0.65-32.31%Miss-
    Mar 17
    		$-0.14$-0.05-180.00%Miss-
    Dec 16
    		$-0.43$-0.35-22.86%Miss-
    Sep 16
    		$-0.40$-0.20-100.00%Miss-

    Key Metrics

    Valuation
    P/E Ratio-2.93EV/EBITDA11014.10x
    Price/FCF-7.73xFCF Yield-12.94%
    Profitability
    Profit Margin-79.20%Operating Margin-21.70%
    ROE-39.50%ROIC-28.53%
    Financial Health
    Debt/Equity0.33xInterest CoverageN/A
    Current Ratio3.34xQuick Ratio2.64x
    Trading Statistics
    Beta2.41Avg Volume4.05M
    52-Week High$2.3852-Week Low$0.84

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.03
    SMA 20$1.00
    SMA 50$0.97
    SMA 200$1.09
    EMA 10$1.02
    EMA 20$1.00
    EMA 50$0.99
    EMA 200$1.08

    MACD

    Line: 0.02Signal: 0.02Hist: -0.00

    ADX

    ADX: 21.8+DI: 20.1-DI: 18.6

    Aroon & PSAR

    Aroon Up84.0
    Aroon Down8.0
    PSAR$1.07

    Bollinger Bands

    Upper Band$1.09
    Lower Band$0.92
    %B Position1676%(Upper)
    Band Width0.45

    RSI (14-Day)

    Neutral
    49.6

    Momentum Oscillators

    Stoch %K32.6
    Stoch %D51.1
    Williams %R-85.0
    ROC (10d)-0.5%
    Momentum-0.01
    CCI (20d)-20.6
    MFI (14d)52.2

    Volatility Measures

    ATR (14d)$0.04(4.1%)
    StdDev (20d)0.04
    Hist Vol39.0%(Moderate)

    Volume Flow

    VWAP$1.00
    OBV-144.2M
    AD Line-1.0B
    CMF (20d)-0.146

    Volume Metrics

    Avg Vol (20d)4.1M
    Vol Ratio0.4x(Low)
    VWMA (20d)$1.01

    Pivot Points

    R3$1.05
    R2$1.03
    R1$1.02
    Pivot Point$1.00
    S1$0.98
    S2$0.96
    S3$0.95

    Advanced Oscillators

    TSI13.54
    Ultimate Osc39.0
    KST91.83

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$13.30M$65.92M$59.60M$65.16M$17.06M$59.89M$54.74M$55.38M$50.94M$59.46M$51.42M$57.63M
    Cost of Revenue$7.99M$50.27M$43.87M$51.92M$11.50M$43.16M$38.58M$38.55M$40.30M$38.08M$34.11M$47.23M
    Gross Profit$5.30M$15.65M$15.73M$13.24M$5.57M$16.73M$16.16M$16.83M$10.65M$21.38M$17.31M$10.40M
    Operating Expenses$73.21M$34.87M$27.86M$29.85M$15.22M$33.28M$50.17M$38.10M$87.40M$67.07M$22.48M$51.70M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$28.21M$32.41M$26.06M$27.98M$23.23M$28.80M$30.89M$35.05M$38.21M$41.23M$42.56M$47.43M
    Operating Income$-67,901,667$-19,216,744$-12,130,394$-16,610,866$-9,649,355$-16,543,056$-34,004,145$-21,271,558$-76,750,414$-45,687,017$-5,176,949$-41,302,902
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$43.80M$26.19M$0$16.11M$72.02M$67.89M$63.14M$68.61M$16.56M$129.55M$94.82M$0
    Income Before Tax$-111,703,499$-45,404,755$-1,023,192$-32,723,935$-81,670,137$-84,430,556$-97,141,588$-89,883,806$-93,315,230$-175,240,873$-99,993,351$-6,462,364
    Income Tax Expense$-619,208$268,378$153,658$213,656$-3,150$219,444$223,522$4.53M$-1,077,649$-815,785$9.47M$1.53M
    Net Income$-111,084,290$-45,673,133$-1,176,851$-32,937,592$-81,389,160$-84,650,000$-94,954,482$-92,909,968$-90,179,575$-164,215,270$-239,970,447$-31,636,185
    EBITDA$-105,852,399$-38,697,489$5.46M$-25,624,082$-73,663,212$-78,243,012$-89,409,780$-81,823,297$-85,765,189$-165,417,170$-91,025,361$6.47M
    EBIT$-111,703,499$-45,404,755$-1,023,192$-32,723,935$-81,670,137$-84,430,556$-97,141,588$-89,883,806$-93,315,230$-175,240,873$-99,993,351$-6,462,364
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CGC

    News

    Canopy Growth (NASDAQ: CGC) logs new insider trade filing

    Canopy Growth (NASDAQ: CGC) reported a new insider trade filing where insider Gedeon Christelle sold 13,344 common shares valued at approximately $20,000 CAD. These shares were granted as Restricted Stock Units (RSUs) on August 22, 2023, and the disposition was related to tax obligations associated with their vesting. Following the transaction, Gedeon Christelle holds 692,162 common shares directly.

    Stock Titan•8/26/26•
    Neutral

    Canopy Growth (NASDAQ:CGC): Can This Penny Stock Turn the Corner?

    Canopy Growth (NASDAQ:CGC) is attracting attention due to cannabis sector momentum, but its long-term viability as a penny stock depends on sustainable operating improvements. The article emphasizes the importance of cannabis demand, cash preservation, and cost discipline as critical factors for the company to strengthen its business economics. Regulatory developments and product mix also play significant roles in Canopy Growth's potential to turn the corner from a penny stock to a more stable investment.

    Kalkine Media•8/25/26•
    Neutral

    Cannabis Operator CGC Rises 15% in a Month: Time to Buy, Hold or Sell?

    Canopy Growth Corporation (CGC) shares have rallied 15% in the past month due to stronger-than-expected Q1 fiscal 2027 earnings, which indicated improving operating performance and growth across its cannabis and vaporization businesses. While the company is making strides towards profitability and efficiency, particularly after the MTL Cannabis acquisition, cash flow remains an area of concern, and margin gains from its Storz & Bickel business may be temporary. Despite improved analyst sentiment, the article suggests a "wait-and-watch" approach due to intense competition and the need for sustained growth.

    TradingView•8/22/26•
    Somewhat-Bullish

    Cannabis Operator CGC Rises 15% in a Month: Time to Buy, Hold or Sell?

    Canopy Growth Corporation (CGC) shares have risen 15% in the last month due to strong Q1 fiscal 2027 earnings, showing growth in all business areas and improving margins. The company's cannabis operations are improving, with increased revenues and a narrowing adjusted EBITDA loss, and its Storz & Bickel vaporization business is recovering. Despite these positive trends, the competitive market and the need for sustained improvement suggest a "Hold" rating, advising investors to watch for continued progress before making new investments.

    The Globe and Mail•8/22/26•
    Somewhat-Bullish

    Cannabis Operator CGC Rises 15% in a Month: Time to Buy, Hold or Sell?

    Canopy Growth Corporation (CGC) has seen a 15% stock rally over the past month due to improved operating performance highlighted in its Q1 fiscal 2027 earnings report. The company's cannabis business and Storz & Bickel vaporization segment show signs of recovery and improved margins, though some margin gains for Storz & Bickel were due to one-time tariff refunds. While operations are improving, the stock currently holds a Zacks Rank #3 (Hold), suggesting a "wait-and-watch" approach for investors given the competitive market and the need for sustained recovery.

    Yahoo Finance•8/22/26•
    Somewhat-Bullish

    Frequently Asked Questions About CGC

    Does CGC pay dividends?
    Canopy Growth Corp (CGC) does not currently pay a regular dividend.
    What is CGC's market cap?
    Canopy Growth Corp (CGC) has a market capitalization of $475.32M with a current stock price of $0.99.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In